Quarterly report pursuant to Section 13 or 15(d)

10. SEGMENTS (Details)

v3.19.3
10. SEGMENTS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Revenues $ 7,222,503 $ 4,230,310 $ 17,312,034 $ 12,928,866  
Cost of product revenue 7,916,220 9,164,109 27,812,635 31,052,519  
Loss from operations (9,050,428) (13,791,400) (33,597,518) (43,741,284)  
Interest and other (expense) income, net       (3,964,174)  
Gain on transfer of plasma center assets 0 0 11,527,421 0  
Loss on extinguishment of debt 0 0 (9,962,495) 0  
Net (loss) income (11,438,459) (15,135,485) (37,718,286) (47,705,458)  
Purchase of property and equipment     2,217,542 1,276,594  
Depreciation and amortization 818,128 847,057 2,429,550 2,522,496  
Total assets 137,779,773 106,345,100 137,779,773 106,345,100 $ 88,876,521
ADMA BioManufacturing          
Revenues 5,869,082 1,985,630 11,215,510 5,796,597  
Cost of product revenue 6,585,143 7,671,279 22,695,870 26,334,602  
Loss from operations (6,007,646) (10,214,933) (25,300,237) (32,656,560)  
Interest and other (expense) income, net (255,384) (255,410) (671,600) (732,623)  
Gain on transfer of plasma center assets     0    
Loss on extinguishment of debt     0    
Net (loss) income (6,263,030) (10,470,343) (25,971,837) (33,389,183)  
Purchase of property and equipment     2,185,554 772,339  
Depreciation and amortization 700,981 651,317 2,077,221 1,922,448  
Total assets 87,400,781 56,123,178 87,400,781 56,123,178  
Plasma Collection Centers          
Revenues 1,317,713 1,317,713 5,989,399 7,025,144  
Cost of product revenue 1,331,077 1,331,077 5,116,765 4,717,917  
Loss from operations (470,263) (470,263) (832,864) (3,238,013)  
Interest and other (expense) income, net 0 0 13,560 (22)  
Gain on transfer of plasma center assets     11,527,421    
Loss on extinguishment of debt     0    
Net (loss) income (470,263) (470,263) 10,708,117 (3,238,035)  
Purchase of property and equipment     31,988 504,255  
Depreciation and amortization 113,957 191,547 342,156 581,059  
Total assets 4,105,208 5,524,105 4,105,208 5,524,105  
Corporate          
Revenues 35,708 35,708 107,125 107,125  
Cost of product revenue 0 0 0 0  
Loss from operations (2,572,519) (2,572,519) (7,464,417) (7,846,711)  
Interest and other (expense) income, net (2,132,647) (2,132,647) (5,027,654) (3,231,529)  
Gain on transfer of plasma center assets     0    
Loss on extinguishment of debt     (9,962,495)    
Net (loss) income (4,705,166) (4,705,166) (22,454,566) (11,078,240)  
Purchase of property and equipment     0 0  
Depreciation and amortization 3,190 4,193 10,173 18,989  
Total assets $ 46,273,784 $ 44,697,817 $ 46,273,784 $ 44,697,817